Publications

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Authors: JT Baeten, ICC Chan, L Moukarzel, AC Carter, M Patel, KH Stopsack, P Pharoa...

E-pub date: 2 Nov 2023

Journal name: Blood

MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach

Authors: M Reinius, A Crombé, T Bradley, R Barker-Clarke, M Crispin-Ortuzar, JD Bre...

E-pub date: 1 Nov 2023

Journal name: Annals of Oncology

HLTF Prevents G4 Accumulation and Promotes G4-induced Fork Slowing to Maintain Genome Stability.

Authors: G Bai, T Endres, U Kühbacher, BH Greer, EM Peacock, MP Crossley, A Sathira...

E-pub date: 27 Oct 2023

Journal name: bioRxiv

Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer

Authors: M Crispin-Ortuzar, R Woitek, MAV Reinius, E Moore, L Beer, V Bura, L Rundo,...

E-pub date: 24 Oct 2023

Journal name: Nat Commun

Dual-modality imaging of immunofluorescence and imaging mass cytometry for whole-slide imaging and accurate segmentation.

Authors: EN Kim, PZ Chen, D Bressan, M Tripathi, A Miremadi, M di Pietro, LM Coussen...

E-pub date: 23 Oct 2023

Journal name: Cell Rep Methods

Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumour immune microenvironment

Authors: X Yang, W Liu, G Macintyre, P Van Loo, F Markowetz, P Bailey, K Yuan

E-pub date: 16 Oct 2023

Journal name:

Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.

Authors: CM Sauer, JA Hall, D-L Couturier, T Bradley, AM Piskorz, J Griffiths, A Saw...

E-pub date: 16 Oct 2023

Journal name: Nat Commun

Cancers make their own luck: theories of cancer origins.

Authors: A Jassim, EP Rahrmann, BD Simons, RJ Gilbertson

E-pub date: 1 Oct 2023

Journal name: Nat Rev Cancer

Filters

Research Groups

Core Facilities

Start date

End date

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach

HLTF Prevents G4 Accumulation and Promotes G4-induced Fork Slowing to Maintain Genome Stability.

Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer

Dual-modality imaging of immunofluorescence and imaging mass cytometry for whole-slide imaging and accurate segmentation.

Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumour immune microenvironment

Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.

Cancers make their own luck: theories of cancer origins.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

MO71-1 Systematic quantification of ovarian tumour heterogeneity using an in silico tissue microarray approach

HLTF Prevents G4 Accumulation and Promotes G4-induced Fork Slowing to Maintain Genome Stability.

Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer

Dual-modality imaging of immunofluorescence and imaging mass cytometry for whole-slide imaging and accurate segmentation.

Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumour immune microenvironment

Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.

Cancers make their own luck: theories of cancer origins.